| __timestamp | Regeneron Pharmaceuticals, Inc. | Ultragenyx Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1271353000 | 45967000 |
| Thursday, January 1, 2015 | 1620577000 | 114737000 |
| Friday, January 1, 2016 | 2052295000 | 183204000 |
| Sunday, January 1, 2017 | 2075142000 | 231644000 |
| Monday, January 1, 2018 | 2186100000 | 293998000 |
| Tuesday, January 1, 2019 | 3036600000 | 357355000 |
| Wednesday, January 1, 2020 | 2735000000 | 412084000 |
| Friday, January 1, 2021 | 2908100000 | 497153000 |
| Saturday, January 1, 2022 | 3592500000 | 705789000 |
| Sunday, January 1, 2023 | 4439000000 | 648449000 |
| Monday, January 1, 2024 | 5132000000 |
Data in motion
In the competitive landscape of biotechnology, research and development (R&D) spending is a critical driver of innovation and growth. Over the past decade, Regeneron Pharmaceuticals, Inc. and Ultragenyx Pharmaceutical Inc. have demonstrated contrasting trajectories in their R&D investments.
Regeneron, a leader in the biotech industry, has consistently increased its R&D budget, with a remarkable 250% growth from 2014 to 2023. This surge underscores their commitment to pioneering new treatments and maintaining a competitive edge. In contrast, Ultragenyx, while smaller in scale, has shown a steady increase in R&D spending, growing by approximately 1,300% over the same period. This reflects their strategic focus on niche markets and rare diseases.
The data highlights the dynamic nature of R&D investments, showcasing how these companies adapt to industry demands and technological advancements.
Research and Development Expenses Breakdown: Regeneron Pharmaceuticals, Inc. vs Blueprint Medicines Corporation
R&D Spending Showdown: Regeneron Pharmaceuticals, Inc. vs Bio-Techne Corporation
Research and Development Investment: Regeneron Pharmaceuticals, Inc. vs Pharming Group N.V.
R&D Spending Showdown: Regeneron Pharmaceuticals, Inc. vs Halozyme Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and Rhythm Pharmaceuticals, Inc.
Analyzing R&D Budgets: Regeneron Pharmaceuticals, Inc. vs Veracyte, Inc.
Research and Development: Comparing Key Metrics for Regeneron Pharmaceuticals, Inc. and Perrigo Company plc
Regeneron Pharmaceuticals, Inc. vs Agios Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and MannKind Corporation
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Verona Pharma plc vs Ultragenyx Pharmaceutical Inc.